Price of TECH with the Market Cap of HALO
If Bio-Techne Corporation (TECH) had the market cap of Halozyme Therapeutics, Inc. (HALO), one TECH would cost $72.94, about the same as today's price of $72.83. Bio-Techne Corporation and Halozyme Therapeutics, Inc. have about the same market cap ($11.44B).
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Bio-Techne Corporation vs Halozyme Therapeutics, Inc.: key figures
| Rank | #1854 | #1850 |
|---|---|---|
| Price | $72.83 | $100.67 |
| Market cap | $11.44B | $11.46B |
| Shares Outstanding | 157.06M | 113.80M |
| Change (1 day) | +0.07% | -0.99% |
| Change (1 year) | +19.88% | +41.41% |
The other way round: HALO with the market cap of TECH
If Halozyme Therapeutics, Inc. (HALO) had the market cap of Bio-Techne Corporation (TECH), one HALO would cost $100.52, about the same as today's price of $100.67.
Price of HALO with the Market Cap of TECHPrice of TECH with the Market Cap of HALO: the last 12 months
The price of one TECH if Bio-Techne Corporation had the market cap of Halozyme Therapeutics, Inc., at the end of each month. Highest: $94.60 (Oct 2026). Lowest: $48.07 (Apr 2026).
- $50.74 Dec 2025
- $54.07 Jan 2026
- $52.50 Feb 2026
- $48.80 Mar 2026
- $48.07 Apr 2026
- $50.43 May 2026
- $59.32 Jun 2026
- $62.81 Jul 2026
- $80.67 Aug 2026
- $83.64 Sep 2026
- $94.60 Oct 2026
- $74.38 Nov 2026
Questions about Bio-Techne Corporation and Halozyme Therapeutics, Inc.
What would the price of Bio-Techne Corporation be with the market cap of Halozyme Therapeutics, Inc.?
If Bio-Techne Corporation (TECH) had the market cap of Halozyme Therapeutics, Inc. (HALO), one TECH would cost $72.94, about the same as today's price of $72.83.
What would the price of Halozyme Therapeutics, Inc. be with the market cap of Bio-Techne Corporation?
If Halozyme Therapeutics, Inc. (HALO) had the market cap of Bio-Techne Corporation (TECH), one HALO would cost $100.52, about the same as today's price of $100.67.
How is this price calculated?
The market cap of Halozyme Therapeutics, Inc. ($11.46B) is divided by the number of TECH in circulation (157.06M). Market cap is the price multiplied by the number of coins or shares in circulation.